IDXX Idexx Laboratories Inc
Price (delayed)
$452.77
Market cap
$36.82B
P/E Ratio
42.04
Dividend/share
N/A
EPS
$10.77
Enterprise value
$37.5B
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and
Highlights
IDXX's price to earnings (P/E) is 25% lower than its 5-year quarterly average of 56.4 and 10% lower than its last 4 quarters average of 46.6
The gross profit has increased by 9% YoY
The quick ratio has decreased by 26% YoY and by 12% QoQ
Key stats
What are the main financial stats of IDXX
Market
Valuations
Earnings
Shares outstanding
81.33M
Market cap
$36.82B
Enterprise value
$37.5B
Price to earnings (P/E)
42.04
Price to book (P/B)
23.24
Price to sales (P/S)
9.58
EV/EBIT
32.86
EV/EBITDA
29.51
EV/Sales
9.62
Revenue
$3.9B
Gross profit
$2.38B
Operating income
$1.13B
Net income
$887.87M
EBIT
$1.14B
EBITDA
$1.27B
Free cash flow
$798.08M
Per share
Balance sheet
Liquidity
EPS
$10.77
EPS diluted
$10.67
Free cash flow per share
$9.68
Book value per share
$19.48
Revenue per share
$47.26
TBVPS
$33.67
Total assets
$3.29B
Total liabilities
$1.7B
Debt
$965.41M
Equity
$1.6B
Working capital
$331.98M
Debt to equity
0.61
Current ratio
1.31
Quick ratio
0.71
Net debt/EBITDA
0.53
Margins
Efficiency
Dividend
EBITDA margin
32.6%
Gross margin
61%
Net margin
22.8%
Operating margin
29%
Return on assets
26.5%
Return on equity
55.8%
Return on invested capital
46.4%
Return on capital employed
51.3%
Return on sales
29.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDXX stock price
How has the Idexx Laboratories stock price performed over time
Intraday
-0.02%
1 week
1.85%
1 month
5.95%
1 year
-18.39%
YTD
9.51%
QTD
9.51%
Financial performance
How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.9B
Gross profit
$2.38B
Operating income
$1.13B
Net income
$887.87M
Gross margin
61%
Net margin
22.8%
The gross profit has increased by 9% YoY
IDXX's revenue is up by 6% year-on-year
The company's net income rose by 5% YoY and by 2.5% QoQ
IDXX's operating income is up by 2.8% YoY
Growth
What is Idexx Laboratories's growth rate over time
Valuation
What is Idexx Laboratories stock price valuation
P/E
42.04
P/B
23.24
P/S
9.58
EV/EBIT
32.86
EV/EBITDA
29.51
EV/Sales
9.62
IDXX's price to earnings (P/E) is 25% lower than its 5-year quarterly average of 56.4 and 10% lower than its last 4 quarters average of 46.6
The company's EPS rose by 6% YoY and by 2.9% QoQ
The price to book (P/B) is 62% less than the 5-year quarterly average of 60.9 and 8% less than the last 4 quarters average of 25.2
The company's equity rose by 7% YoY
The P/S is 22% below the 5-year quarterly average of 12.3 and 10% below the last 4 quarters average of 10.6
IDXX's revenue is up by 6% year-on-year
Efficiency
How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 22% YoY
The return on assets has declined by 6% year-on-year but it rose by 2.3% since the previous quarter
Idexx Laboratories's return on invested capital has increased by 4.3% YoY
The company's return on sales fell by 2.7% YoY
Dividends
What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDXX.
Financial health
How did Idexx Laboratories financials performed over time
The company's total assets is 94% higher than its total liabilities
The quick ratio has decreased by 26% YoY and by 12% QoQ
IDXX's current ratio is down by 17% year-on-year and by 8% since the previous quarter
The debt is 39% less than the equity
IDXX's debt to equity is down by 14% YoY
The debt has contracted by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.